Scutellarin Exerts Hypoglycemic and Renal Protective Effects in db/db Mice via the Nrf2/HO-1 Signaling Pathway
Eight weeks of SCU and Met treatment regulated the levels of (a) triglyceride, (b) total cholesterol, and (c) high-density lipoprotein cholesterol in serum of db/db mice. Results are represented as (). and in a comparison with the db/m+ mice, ,, and in a comparison with the vehicle-treated db/db mice. SCU: scutellarin; Met: metformin.